Collecting this in one place because it comes up every few weeks and the answer is always assembled from scratch. It is about cross-border ordering, and it is deliberately narrow — everything I am not confident about is marked as such.
What is actually established
The variables that decide how a cross-border order goes are declaration wording, the destination country's import rules for prescription medicines, and whether the shipment looks commercial. Personal-import allowances exist in some jurisdictions and not in others, and where they exist they are usually conditional on a prescription and a quantity limit. The failure mode is normally a seizure notice rather than anything worse, and a reshipment policy is the thing worth confirming before ordering rather than after.
The condition it depends on
Cold chain is the underrated risk on long routes. A shipment held at a border for a week has had a temperature excursion whether or not it arrives.
What I am not sure about
What would genuinely help is knowing which of the variables in a cross-border order actually determine the outcome, and which are superstition. Numbers rather than impressions, if you have them.
Dr.SurgeonPGH said:The variables that decide how a cross-border order goes are declaration wording, the destination country's import rules for prescription medicines,…
Agreed, with a caveat about community reputation: it is a lagging indicator. Reports arrive weeks after orders, so a supplier can look excellent for a month after quality has already changed.
Dr.SurgeonPGH said:The variables that decide how a cross-border order goes are declaration wording, the destination country's import rules for prescription medicines,…
This is where I part company with the consensus forming above. Import rules are jurisdiction-specific and this board keeps giving US-shaped answers to non-US questions. What is a personal-import allowance in one country is a controlled-import offence in another.
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsShort answer first, then the reasoning. Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion. Synthesis, testing, and cold-chain shipping have floors. A price well under the floor means something was skipped, and the two things that get skipped are testing and content.
If somebody has the primary source to hand I would rather cite it than paraphrase it.
LarryQC_SD said:Agreed, with a caveat about community reputation: it is a lagging indicator.
Can confirm. Same sequence, different timescale.